SynthesisThe Cochrane database of systematic reviews2018

Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia.

Eu Chang Hwang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.